Impact de l'évaluation gériatrique sur la décision de traitement en oncologie thoracique

Geriatric assessment should be integrated into treatment decision-making for patients with primary lung cancer aged more than 70 years, particularly those where frailty is a concern. Folstein's MMSE was predictive in our study for changes in decision-making.